[go: up one dir, main page]

CN111233810B - Preparation method and application of hydroxycinnamoyl ester type catechin - Google Patents

Preparation method and application of hydroxycinnamoyl ester type catechin Download PDF

Info

Publication number
CN111233810B
CN111233810B CN202010056390.XA CN202010056390A CN111233810B CN 111233810 B CN111233810 B CN 111233810B CN 202010056390 A CN202010056390 A CN 202010056390A CN 111233810 B CN111233810 B CN 111233810B
Authority
CN
China
Prior art keywords
trans
add
epigallocatechin
epicatechin
tert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010056390.XA
Other languages
Chinese (zh)
Other versions
CN111233810A (en
Inventor
鲍官虎
王威
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui Agricultural University AHAU
Original Assignee
Anhui Agricultural University AHAU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui Agricultural University AHAU filed Critical Anhui Agricultural University AHAU
Priority to CN202010056390.XA priority Critical patent/CN111233810B/en
Publication of CN111233810A publication Critical patent/CN111233810A/en
Application granted granted Critical
Publication of CN111233810B publication Critical patent/CN111233810B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a preparation method and application of hydroxycinnamoyl ester type catechin. The hydroxycinnamoyl catechin includes 4 kinds of catechins named as epicatechin trans-coumarate, epicatechin trans-caffeate, epigallocatechin trans-coumarate and epigallocatechin trans-caffeate, respectively. The 4 hydroxycinnamoyl ester catechins are prepared by performing four steps of total acetylation, acetyl removal on phenolic hydroxyl, phenolic hydroxyl silanization and 3-bit acetyl removal on epicatechin and epigallocatechin, and then respectively performing esterification and protective group removal on the epicatechin and the epigallocatechin and acetyl chloride of acetylated caffeic acid or coumaric acid. The 4 hydroxycinnamoyl ester type catechins have certain inhibiting effect on alpha-glucosidase activity, can be used for hypoglycemic drugs, and have important significance in the fields of agriculture and medicine.

Description

一类羟基肉桂酰酯型儿茶素的制备方法和用途Preparation method and application of a class of hydroxycinnamoyl catechins

技术领域technical field

本发明属于天然药物化学技术领域,具体涉及四种名分别为表儿茶素反式香豆酸酯、表儿茶素反式咖啡酸酯、表没食子儿茶素反式香豆酸酯与表没食子儿茶素反式咖啡酸酯的羟基肉桂酰酯型儿茶素的制备方法和应用。The invention belongs to the technical field of natural medicinal chemistry, and specifically relates to four kinds of drugs named respectively epicatechin trans coumarate, epicatechin trans caffeate, epigallocatechin trans coumarate and epigallocatechin trans coumarate and epigallocatechin The preparation method and application of the hydroxycinnamoyl ester type catechin of gallocatechin trans-caffeate.

背景技术Background technique

茶叶中含有丰富的茶多酚,占茶叶干物质的18%-36%。其中,大部分是儿茶素(黄烷醇类),占茶叶干物质的12%-24%。研究表明,儿茶素是茶叶中重要的滋味物质。而且,儿茶素还具有抗炎、抗氧化、抗癌、心血管和神经保护作用等药理功能。Tea is rich in tea polyphenols, accounting for 18%-36% of the dry matter of tea. Among them, most of them are catechins (flavanols), accounting for 12%-24% of the dry matter of tea leaves. Studies have shown that catechin is an important taste substance in tea. Moreover, catechins also have pharmacological functions such as anti-inflammatory, anti-oxidation, anti-cancer, cardiovascular and neuroprotective effects.

化学合成实验通常都需要特殊的反应条件,反应所使用的药品试剂通常危险性较大。现有技术中公开的这类儿茶素的合成方法复杂,反应条件苛刻,一般实验室的条件满足不了反应要求,无法完成制备。如何在现有制备方法和反应原料中进行筛选,设计出方法简单、条件温和的该四种羟基肉桂酰酯型儿茶素制备方法,具有重要的意义。Chemical synthesis experiments usually require special reaction conditions, and the pharmaceutical reagents used in the reaction are usually more dangerous. The synthesis method of this type of catechin disclosed in the prior art is complicated, and the reaction conditions are harsh, and the conditions of general laboratories cannot meet the reaction requirements, and the preparation cannot be completed. How to screen the existing preparation methods and reaction materials, and design a preparation method of the four hydroxycinnamoyl catechins with simple methods and mild conditions is of great significance.

发明内容Contents of the invention

本发明要解决的技术问题为克服现有技术中的不足之处,提供一种一类羟基肉桂酰酯型儿茶素的制备方法。The technical problem to be solved by the present invention is to overcome the deficiencies in the prior art and provide a preparation method of a class of hydroxycinnamoyl catechins.

本发明要解决的又一个技术问题为提供一种上述方法制备的一类羟基肉桂酰酯型儿茶素对α-葡萄糖苷酶的抑制作用,可应用于制备降血糖药物。Another technical problem to be solved by the present invention is to provide an inhibitory effect of a class of hydroxycinnamoyl ester catechins prepared by the above method on α-glucosidase, which can be applied to the preparation of hypoglycemic drugs.

为解决本发明的技术问题,所提供的技术方案为:In order to solve the technical problems of the present invention, the technical solution provided is:

一类羟基肉桂酰酯型儿茶素的制备方法,该类羟基肉桂酰酯型儿茶素包括4种儿茶素,该4种儿茶素的名称分别为表儿茶素反式香豆酸酯即(–)-epicatechin 3-O-p-coumaroate、表儿茶素反式咖啡酸酯即(–)-epicatechin3-O-caffeoate、表没食子儿茶素反式香豆酸酯即(–)-epigallocatechin3-O-p-coumaroate、表没食子儿茶素反式咖啡酸酯即(–)-epigallocatechin3-O-caffeoate,其结构式分别如式Ⅰ、式Ⅱ、式Ⅲ和式Ⅳ所示,A method for preparing a class of hydroxycinnamoyl ester catechins. The hydroxycinnamoyl ester catechins include 4 kinds of catechins, and the names of the 4 kinds of catechins are respectively epicatechin trans-coumaric acid Ester (–)-epicatechin 3-O-p-coumaroate, Epigallocatechin trans-coumarate (–)-epigallocatechin3 -O-p-coumaroate, epigallocatechin trans-caffeoate (–)-epigallocatechin3-O-caffeoate, the structural formulas are shown in formula Ⅰ, formula Ⅱ, formula Ⅲ and formula Ⅳ respectively,

Figure BDA0002373026030000021
Figure BDA0002373026030000021

该类羟基肉桂酰酯型儿茶素的制备方法包括如下步骤:The preparation method of the hydroxycinnamoyl ester type catechin comprises the following steps:

S1、以表儿茶素即EC为原料,通过全乙酰化、脱去酚羟基上的乙酰基、酚羟基硅烷化及脱去3位乙酰基四个反应后制得5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素;S1. Using epicatechin (EC) as a raw material, 5,7,3', 4'-O-tetra-tert-butyldimethylsilyl-epicatechin;

以表没食子儿茶素即EGC为原料,通过全乙酰化、脱去酚羟基上的乙酰基、酚羟基硅烷化及脱去3位乙酰基四个反应后制得5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素;Using epigallocatechin (EGC) as a raw material, 5,7,3',4 is prepared by four reactions: full acetylation, removal of acetyl group on phenolic hydroxyl group, silylation of phenolic hydroxyl group and removal of 3-position acetyl group. ',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin;

S2、制备3”,4”-O-二乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素反式咖啡酸酯;S2. Preparation of 3”, 4”-O-diacetyl-5,7,3’,4’-O-tetra-tert-butyldimethylsilyl-epicatechin trans-caffeate;

称取92.0mg步骤S1制得的5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素于25mL圆底烧瓶中,加入0.2mL干燥的吡啶,2.0mL干燥的二氯甲烷,在冰浴条件下缓慢滴加含有0.18mmol的3,4-O-二乙酰化咖啡酰氯的干燥二氯甲烷3.0mL,室温反应过夜,加适量的水和等体积的二氯甲烷萃取三次,二氯甲烷层用无水硫酸钠干燥后浓缩,经硅胶柱层析以石油醚:乙酸乙酯=30:1进行洗脱后得到3”,4”-O-二乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素反式咖啡酸酯;Weigh 92.0 mg of 5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin prepared in step S1 into a 25 mL round bottom flask, add 0.2 mL of dry pyridine, 2.0 mL of dry dichloromethane, slowly add 3.0 mL of dry dichloromethane containing 0.18 mmol of 3,4-O-diacetylated caffeoyl chloride dropwise under ice bath conditions, react overnight at room temperature, add appropriate amount of water and an equal volume of Dichloromethane was extracted three times, and the dichloromethane layer was dried over anhydrous sodium sulfate and concentrated. After silica gel column chromatography was eluted with petroleum ether: ethyl acetate = 30:1 to obtain 3”, 4”-O-diacetyl -5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin trans-caffeate;

S3、制备4”-O-乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素反式香豆酸酯;S3. Preparation of 4"-O-acetyl-5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin trans-coumarate;

称取395.0mg步骤S1制得的5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素于25mL圆底烧瓶中,加入1.5mL干燥的吡啶,3.0mL干燥的二氯甲烷,在冰浴条件下缓慢滴加含有0.80mmol的4-O-乙酰化香豆酰氯的干燥二氯甲烷5.0mL,室温反应过夜,加适量的水和等体积的二氯甲烷萃取三次,二氯甲烷层用无水硫酸钠干燥后浓缩,经硅胶柱层析,以石油醚:乙酸乙酯=50:1进行洗脱后得到4”-O-乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素反式香豆酸酯;Weigh 395.0 mg of 5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin prepared in step S1 into a 25 mL round bottom flask, add 1.5 mL of dry pyridine, 3.0 mL of dry dichloromethane, slowly add 5.0 mL of dry dichloromethane containing 0.80 mmol of 4-O-acetylated coumaryl chloride dropwise under ice bath conditions, react overnight at room temperature, add appropriate amount of water and an equal volume of dichloromethane Methane was extracted three times, the dichloromethane layer was dried over anhydrous sodium sulfate and concentrated, and silica gel column chromatography was eluted with petroleum ether: ethyl acetate = 50:1 to obtain 4”-O-acetyl-5,7 ,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin trans-coumarate;

S4、制备3”,4”-O-二乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素反式咖啡酸酯;S4. Preparation of 3", 4"-O-diacetyl-5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin trans-caffeate ;

称取500.0mg步骤S1制得的5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素于100mL圆底烧瓶中,加入2.0mL干燥的吡啶,5.0mL干燥的二氯甲烷,在冰浴条件下缓慢滴加含有1.9mmol的3,4-O-二乙酰化咖啡酰氯的干燥二氯甲烷8.0mL,室温反应过夜,加适量的水和等体积的二氯甲烷萃取三次,二氯甲烷层用无水硫酸钠干燥后浓缩,经硅胶柱层析以石油醚:乙酸乙酯=30:1进行洗脱后得到3”,4”-O-二乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素反式咖啡酸酯;Weigh 500.0mg of 5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin prepared in step S1 into a 100mL round bottom flask, add 2.0mL to dry Pyridine, 5.0 mL of dry dichloromethane, slowly add 8.0 mL of dry dichloromethane containing 1.9 mmol of 3,4-O-diacetylated caffeoyl chloride dropwise under ice bath conditions, react overnight at room temperature, add appropriate amount of water and an equal volume of dichloromethane for three extractions, the dichloromethane layer was dried over anhydrous sodium sulfate and concentrated, and eluted with petroleum ether: ethyl acetate = 30:1 by silica gel column chromatography to obtain 3”, 4”- O-diacetyl-5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin trans-caffeate;

S5、制备4”-O-乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素反式香豆酸酯;S5. Preparation of 4"-O-acetyl-5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin trans-coumarate;

称取370.0mg步骤S1制得的5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素于100mL圆底烧瓶中,加入2.0mL干燥的吡啶,5.0mL干燥的二氯甲烷,在冰浴条件下缓慢滴加含有1.5mmol的4-O-乙酰化香豆酰氯的干燥二氯甲烷7.0mL,室温反应过夜,加适量的水和等体积的二氯甲烷萃取三次,二氯甲烷层用无水硫酸钠干燥后浓缩,经硅胶柱层析以石油醚:乙酸乙酯=50:1进行洗脱后得到4”-O-乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素反式香豆酸酯;Weigh 370.0mg of 5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin prepared in step S1 into a 100mL round bottom flask, add 2.0mL to dry Pyridine, 5.0 mL of dry dichloromethane, slowly add 7.0 mL of dry dichloromethane containing 1.5 mmol of 4-O-acetylated coumaryl chloride dropwise under ice bath conditions, react overnight at room temperature, add appropriate amount of water and etc. The volume of dichloromethane was extracted three times, the dichloromethane layer was dried with anhydrous sodium sulfate and then concentrated, and 4”-O-acetyl- 5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin trans-coumarate;

S6、制备表儿茶素反式咖啡酸酯;S6, preparing epicatechin trans-caffeate;

称取164.0mg步骤S2制得的3”,4”-O-二乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素反式咖啡酸酯于25mL圆底烧瓶中,加入28.0mg氟氢化钾,再加入6.0mL干燥的甲醇,50℃下反应6小时,反应产物经LH-20凝胶柱层析,以甲醇洗脱后得到表儿茶素反式咖啡酸酯;Weigh 164.0 mg of 3",4"-O-diacetyl-5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin trans coffee prepared in step S2 In a 25mL round-bottomed flask, add 28.0mg potassium bifluoride, then add 6.0mL dry methanol, and react at 50°C for 6 hours. The reaction product is eluted with methanol to obtain the following table: Catechin trans caffeate;

S7、制备表没食子儿茶素反式咖啡酸酯;S7, preparing epigallocatechin trans-caffeate;

称取60.0mg步骤S4制得的3”,4”-O-二乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素反式咖啡酸酯于25mL圆底烧瓶中,加入200.0mg氟氢化钾,再加入5.0mL干燥的甲醇,50℃下反应6小时,反应产物经LH-20凝胶柱层析,以甲醇洗脱后得到表没食子儿茶素反式咖啡酸酯;Weigh 60.0 mg of 3",4"-O-diacetyl-5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin prepared in step S4 Add 200.0mg of potassium bifluoride to a 25mL round bottom flask, then add 5.0mL of dry methanol, and react at 50°C for 6 hours. The reaction product is subjected to LH-20 gel column chromatography and washed with methanol. After taking off, epigallocatechin trans-caffeate is obtained;

S8、制备表儿茶素反式香豆酸酯;S8, preparing epicatechin trans-coumarate;

称取163.0mg步骤S3制得的4”-O-乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素反式香豆酸酯于25mL圆底烧瓶中,加入136.0mg氟氢化钾,再加入6.0mL干燥的甲醇,室温下反应3.5小时,待反应结束后加入适量的水,用等体积的乙酸乙酯萃取三次,乙酸乙酯层用无水硫酸钠干燥后浓缩,经硅胶柱层析以石油醚:乙酸乙酯=1:1进行洗脱后得到4”-O-乙酰基-表儿茶素反式香豆酸酯;Weigh 163.0 mg of 4"-O-acetyl-5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin trans-coumarate prepared in step S3 in In a 25mL round bottom flask, add 136.0mg potassium bifluoride, then add 6.0mL dry methanol, react at room temperature for 3.5 hours, add an appropriate amount of water after the reaction is completed, extract three times with an equal volume of ethyl acetate, and the ethyl acetate layer After drying with anhydrous sodium sulfate and concentrating, 4"-O-acetyl-epicatechin trans-coumarate was obtained after silica gel column chromatography was eluted with petroleum ether: ethyl acetate = 1:1;

称取50.0mg的4”-O-乙酰基-表儿茶素反式香豆酸酯于10mL圆底烧瓶中,加450.0mg醋酸铵,加入体积分数为80%甲醇水溶液2.0mL,室温反应5.5小时,反应产物经LH-20凝胶柱层析,以甲醇洗脱后得到表儿茶素反式香豆酸酯;Weigh 50.0 mg of 4”-O-acetyl-epicatechin trans-coumarate into a 10 mL round bottom flask, add 450.0 mg of ammonium acetate, add 2.0 mL of 80% methanol aqueous solution, and react at room temperature for 5.5 hour, the reaction product was subjected to LH-20 gel column chromatography, and was eluted with methanol to obtain epicatechin trans-coumarate;

S9、制备表没食子儿茶素反式香豆酸酯;S9, preparing epigallocatechin trans-coumarate;

称取130.0mg步骤S5制得的4”-O-乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素反式香豆酸酯于25mL圆底烧瓶中,加入476.0mg氟氢化钾,再加入8.0mL干燥的甲醇,50℃下反应6小时,反应产物浓缩后经LH-20凝胶柱层析,以甲醇洗脱后得到4”-O-乙酰基-表没食子儿茶素反式香豆酸酯;Weigh 130.0 mg of 4"-O-acetyl-5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin trans-aroma prepared in step S5 Add 476.0mg of potassium fluoride to a 25mL round-bottomed flask, then add 8.0mL of dry methanol, and react at 50°C for 6 hours. The reaction product is concentrated and eluted with methanol through LH-20 gel column chromatography Finally, 4"-O-acetyl-epigallocatechin trans-coumarate was obtained;

称取36.0mg的4”-O-乙酰基-表没食子儿茶素反式香豆酸酯于10mL圆底烧瓶中,加460.0mg醋酸铵,加入体积分数为80%甲醇水溶液2.0mL,室温反应5小时,反应产物经LH-20凝胶柱层析,以甲醇洗脱后得到表没食子儿茶素反式香豆酸酯;Weigh 36.0mg of 4”-O-acetyl-epigallocatechin trans-coumarate into a 10mL round bottom flask, add 460.0mg of ammonium acetate, add 2.0mL of 80% methanol aqueous solution, and react at room temperature After 5 hours, the reaction product was subjected to LH-20 gel column chromatography and eluted with methanol to obtain epigallocatechin trans-coumarate;

其中步骤S2、S3、S4、S5不分先后顺序,步骤S6、S7、S8、S9不分先后顺序。The steps S2, S3, S4, and S5 are in no particular order, and the steps S6, S7, S8, and S9 are in no particular order.

作为一类羟基肉桂酰酯型儿茶素的制备方法的进一步改进,As a further improvement of the preparation method of a class of hydroxycinnamoyl ester catechins,

优选的,步骤S2中所述的3,4-O-二乙酰化咖啡酰氯通过以下方式制得:Preferably, the 3,4-O-diacetylated caffeoyl chloride described in step S2 is prepared in the following manner:

称取180.1mg咖啡酸于25mL圆底烧瓶中,加入0.3mL干燥的吡啶,0.5mL醋酸酐,在干燥管保护下室温搅拌过夜。待反应结束后,加入水终止反应,经旋转蒸干后即可得到乙酰化咖啡酸即3,4-O-二乙酰化咖啡酸;将反应后的乙酰化咖啡酸转至50mL圆底烧瓶中,加入10mL亚硫酰氯,于90℃加热回流3小时即可得到粗品3,4-O-二乙酰化咖啡酰氯,保存备用。Weigh 180.1 mg of caffeic acid into a 25 mL round bottom flask, add 0.3 mL of dry pyridine and 0.5 mL of acetic anhydride, and stir overnight at room temperature under the protection of a drying tube. After the reaction is finished, add water to terminate the reaction, and then 3,4-O-diacetylated caffeic acid can be obtained after rotary evaporation to dryness; transfer the reacted acetylated caffeic acid to a 50mL round bottom flask , add 10 mL of thionyl chloride, and heat to reflux at 90°C for 3 hours to obtain crude 3,4-O-diacetylated caffeoyl chloride, which is stored for future use.

优选的,步骤S3中所述的4-O-乙酰化香豆酰氯通过以下方式制得:Preferably, the 4-O-acetylated coumaryl chloride described in step S3 is prepared in the following manner:

称取656.0mg香豆酸于25mL圆底烧瓶中,加入0.8mL干燥的吡啶,1.0mL醋酸酐,在干燥管保护下室温搅拌过夜。待反应结束后,加入水终止反应,经旋转蒸干后即可得到乙酰化香豆酸;将反应后的乙酰化香豆酸转至25mL圆底烧瓶中,加入3.0mL亚硫酰氯,于90℃加热回流3小时即可得到粗品4-O-乙酰化香豆酰氯,保存备用。Weigh 656.0 mg of coumaric acid into a 25 mL round bottom flask, add 0.8 mL of dry pyridine and 1.0 mL of acetic anhydride, and stir overnight at room temperature under the protection of a drying tube. After the reaction is finished, add water to terminate the reaction, and then obtain acetylated coumaric acid after rotary evaporation; transfer the reacted acetylated coumaric acid to a 25mL round-bottomed flask, add 3.0mL of thionyl chloride, and dissolve at 90 The crude product 4-O-acetylated coumaroyl chloride can be obtained by heating at reflux at ℃ for 3 hours, which is stored for future use.

为解决本发明的又一个技术问题,所提供的又一个技术方案为,采用上述制备方法制得的一类羟基肉桂酰酯型儿茶素在制备降血糖药物上的用途。In order to solve another technical problem of the present invention, another technical solution provided is the use of a class of hydroxycinnamoyl ester catechins prepared by the above-mentioned preparation method in the preparation of hypoglycemic drugs.

作为一类羟基肉桂酰酯型儿茶素在制备降血糖药物上的用途的进一步改进,所述降血糖药物包括口服型和注射型,所述口服型包括片剂、胶囊剂、颗粒剂、滴丸剂,所述注射型包括注射液、混旋液。As a further improvement of the use of a class of hydroxycinnamoyl ester catechins in the preparation of hypoglycemic drugs, the hypoglycemic drugs include oral and injection types, and the oral types include tablets, capsules, granules, drops, etc. Pills, the injection type includes injection and suspension.

本发明相比现有技术的有益效果在于:The beneficial effect of the present invention compared with prior art is:

1)本发明提供了四种羟基肉桂酰酯型儿茶素的合成方法,与现有技术的合成方法不同,本合成实验所采用的羟基保护基团、酯化反应条件以及对保护基团的水解条件等具有明显的优势,该制备方法简单,条件温和,容易实施,成本较低,具有非常好的应用前景1) The present invention provides the synthetic method of four kinds of hydroxycinnamoyl ester type catechins, different from the synthetic method of prior art, the hydroxyl protecting group that this synthetic experiment adopts, esterification reaction condition and to protecting group The hydrolysis conditions have obvious advantages, the preparation method is simple, the conditions are mild, easy to implement, the cost is low, and it has very good application prospects

2)本发明制备的四种羟基肉桂酰酯型儿茶素具有医学活性,对α-葡萄糖苷酶活性有一定抑制作用,可以用于制备口服型和注射型的降血糖药物,对农业和医药领域具有重要的意义。2) The four hydroxycinnamoyl ester catechins prepared by the present invention have medical activity, and have a certain inhibitory effect on α-glucosidase activity, and can be used to prepare oral and injection hypoglycemic drugs, which are beneficial to agriculture and medicine. field is of great importance.

附图说明Description of drawings

图1为四种羟基肉桂酰酯型儿茶素的合成路径;Fig. 1 is the synthetic route of four kinds of hydroxycinnamoyl ester type catechins;

附图中标记的含义如下:The meanings of the marks in the accompanying drawings are as follows:

1a、3,5,7,3’,4’-O-五乙酰基-表儿茶素1a, 3,5,7,3’,4’-O-pentaacetyl-epicatechin

1b、3,5,7,3’,4’,5’-O-六乙酰基-表没食子儿茶素1b, 3,5,7,3',4',5'-O-hexaacetyl-epigallocatechin

2a、3-O-乙酰基-表儿茶素2a, 3-O-acetyl-epicatechin

2b、3-O-乙酰基-表没食子儿茶素2b, 3-O-acetyl-epigallocatechin

3a、3-O-乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素3a, 3-O-acetyl-5,7,3’,4’-O-tetra-tert-butyldimethylsilyl-epicatechin

3b、3-O-乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素3b, 3-O-acetyl-5,7,3’,4’,5’-O-penta-tert-butyldimethylsilyl-epigallocatechin

4a、5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素4a, 5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin

4b、5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素4b, 5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin

5a、3,4-O-二乙酰化咖啡酰氯5a, 3,4-O-diacetylated caffeoyl chloride

5b、4-O-乙酰化香豆酰氯5b, 4-O-acetylated coumaryl chloride

6a、3”,4”-O-二乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素反式咖啡酸酯6a, 3”, 4”-O-diacetyl-5,7,3’,4’-O-tetra-tert-butyldimethylsilyl-epicatechin trans-caffeate

6b、4”-O-乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素反式香豆酸酯6b, 4”-O-acetyl-5,7,3’,4’-O-tetra-tert-butyldimethylsilyl-epicatechin trans-coumarate

6c、3”,4”-O-二乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素反式咖啡酸酯6c, 3”, 4”-O-diacetyl-5,7,3’,4’,5’-O-penta-tert-butyldimethylsilyl-epigallocatechin trans-caffeate

6d、4”-O-乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素反式香豆酸酯6d, 4"-O-acetyl-5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin trans-coumarate

7a、4”-O-乙酰基-表儿茶素反式香豆酸酯7a, 4"-O-acetyl-epicatechin trans-coumarate

7b、4”-O-乙酰基-表没食子儿茶素反式香豆酸酯7b, 4”-O-acetyl-epigallocatechin trans-coumarate

8a、表儿茶素反式咖啡酸酯8a, epicatechin trans caffeate

8b、表儿茶素反式香豆酸酯8b, epicatechin trans-coumarate

8c、表没食子儿茶素反式咖啡酸酯8c, epigallocatechin trans caffeate

8d、表没食子儿茶素反式香豆酸酯8d. Epigallocatechin trans-coumarate

具体实施方式Detailed ways

下面结合实施例对本发明作进一步描述:The present invention will be further described below in conjunction with embodiment:

本部分对本发明实验中所使用到的材料以及实验方法进行一般性的描述。虽然为实现本发明目的所使用的许多材料和操作方法是本领域公知的,但是本发明在此作尽可能详细描述。本领域技术人员清楚,在下文中,如果未特别说明,本发明所用材料、设备和操作方法是本领域公知的。This section generally describes the materials and experimental methods used in the experiments of the present invention. While many of the materials and manipulations which are employed for the purposes of the invention are well known in the art, the invention has been described here in as much detail as possible. It will be clear to those skilled in the art that in the following, unless otherwise specified, the materials, equipment and operation methods used in the present invention are well known in the art.

实施例1Example 1

表儿茶素反式香豆酸酯、表儿茶素反式咖啡酸酯、表没食子儿茶素反式香豆酸酯与表没食子儿茶素反式咖啡酸酯的羟基肉桂酰酯型儿茶素的制备;Epigallocatechin transcoumarate, epicatechin transcaffeate, epigallocatechin transcoumarate and epigallocatechin transcaffeate hydroxycinnamoyl ester type The preparation of tea;

1.1仪器与试剂1.1 Instruments and reagents

1H核磁共振谱采用Agilent DD2600 MHz核磁共振仪;质谱采用Agilent6465UPLC-Q-TOF-MS。 1 H nuclear magnetic resonance spectrum adopts Agilent DD2600 MHz nuclear magnetic resonance instrument; mass spectrometry adopts Agilent6465UPLC-Q-TOF-MS.

表儿茶素(EC)和表没食子儿茶素(EGC)分别购买于成都生物制药有限公司和湖北巨胜科技有限公司;咖啡酸和对香豆酸购买于安耐吉化学;其它试剂均为国产分析纯。Epicatechin (EC) and epigallocatechin (EGC) were purchased from Chengdu Biopharmaceutical Co., Ltd. and Hubei Jusheng Technology Co., Ltd.; caffeic acid and p-coumaric acid were purchased from Anaiji Chemical; other reagents were Domestic analytically pure.

1.2表儿茶素反式香豆酸酯、表儿茶素反式咖啡酸酯、表没食子儿茶素反式香豆酸酯与表儿茶素反式咖啡酸酯的羟基肉桂酰酯型儿茶素的合成路线如图1所示;1.2 Epicatechin trans-coumarate, epicatechin trans-caffeate, epigallocatechin trans-coumarate and epicatechin trans-caffeate hydroxycinnamoyl esters The synthetic route of tea element is as shown in Figure 1;

1.3具体实施方法:1.3 Specific implementation methods:

化合物1a的合成:Synthesis of compound 1a:

称取1.16g(4.0mmol)表儿茶素(EC)于50mL圆底烧瓶中,加入6.0mL干燥的吡啶,8.0mL醋酸酐(84.6mmol),在干燥管保护下室温搅拌过夜。待反应结束后,加入水终止反应,经旋转蒸干后即可得到EC全乙酰化产物3,5,7,3’,4’-O-五乙酰基-表儿茶素(1a,1.9g,白色粉末,收率95%)。1H NMR(600MHz,CDCl3):7.33(1H,s),7.25(1H,d,J=8.4Hz),7.18(1H,d,J=8.4Hz),6.65(1H,br s),6.55(1H,br s),5.37(1H,br s),5.09(1H,s),2.95(1H,dd,J=18.0,4.2Hz),2.87(1H,br d,J=18.0Hz),2.27(9H,s),2.26(3H,s),1.90(3H,s)。Weigh 1.16g (4.0mmol) of epicatechin (EC) into a 50mL round bottom flask, add 6.0mL of dry pyridine and 8.0mL of acetic anhydride (84.6mmol), and stir overnight at room temperature under the protection of a drying tube. After the reaction was completed, water was added to terminate the reaction, and the EC peracetylated product 3,5,7,3',4'-O-pentaacetyl-epicatechin (1a, 1.9g , white powder, yield 95%). 1 H NMR (600MHz, CDCl 3 ): 7.33 (1H, s), 7.25 (1H, d, J = 8.4Hz), 7.18 (1H, d, J = 8.4Hz), 6.65 (1H, br s), 6.55 (1H,br s),5.37(1H,br s),5.09(1H,s),2.95(1H,dd,J=18.0,4.2Hz),2.87(1H,br d,J=18.0Hz),2.27 (9H,s),2.26(3H,s),1.90(3H,s).

化合物1b的合成:Synthesis of compound 1b:

称取1.2g(3.9mmol)表没食子儿茶素(EGC)于50mL圆底烧瓶中,加入6.0mL干燥的吡啶,10.0mL醋酸酐(105.7mmol),在干燥管保护下室温搅拌过夜。待反应结束后,加入水终止反应,经旋转蒸干后即可得到EGC全乙酰化产物:3,5,7,3’,4’,5’-O-六乙酰基-表没食子儿茶素(1b,2.1g,白色粉末,收率94%)。1H NMR(600MHz,CDCl3):7.20(2H,s),6.65(1H,brs),6.55(1H,br s),5.36(1H,br s),5.07(1H,s),2.94(1H,dd,J=18.0,4.2Hz),2.88(1H,br d,J=17.4Hz),2.25-2.28(15H,m),1.92(3H,s)。Weigh 1.2g (3.9mmol) of epigallocatechin (EGC) into a 50mL round bottom flask, add 6.0mL of dry pyridine, 10.0mL of acetic anhydride (105.7mmol), and stir overnight at room temperature under the protection of a drying tube. After the reaction is finished, add water to terminate the reaction, and after rotary evaporation to dryness, the EGC peracetylated product can be obtained: 3,5,7,3',4',5'-O-hexaacetyl-epigallocatechin (1b, 2.1g, white powder, yield 94%). 1 H NMR (600MHz, CDCl 3 ): 7.20(2H,s), 6.65(1H,brs), 6.55(1H,brs), 5.36(1H,brs), 5.07(1H,s), 2.94(1H , dd, J = 18.0, 4.2Hz), 2.88 (1H, br d, J = 17.4Hz), 2.25-2.28 (15H, m), 1.92 (3H, s).

化合物2a的合成:Synthesis of compound 2a:

称取500.0mg(1.0mmol)化合物1a于100mL圆底烧瓶中,加入80%甲醇水溶液50mL,7.8g(101.2mmol)醋酸铵,室温搅拌过夜。待反应结束后,加入适量的水,经旋转浓缩去除甲醇,用等体积的乙酸乙酯萃取三次,浓缩乙酸乙酯层,经硅胶柱层析,以乙酸乙酯:甲醇=20:1进行洗脱后得到化合物3-O-乙酰基-表儿茶素(2a,259.0mg,白色粉末,收率78%)。1HNMR(600MHz,DMSO-d6):9.29(1H,s),9.02(1H,s),8.92(1H,s),8.83(1H,s),6.83(1H,s),6.69(1H,d,J=8.4Hz),6.65(1H,d,J=7.8Hz),5.93(1H,s),5.76(1H,s),5.23(1H,br s),4.93(1H,s),2.87(1H,dd,J=17.4,4.2Hz),2.58(1H,br d,J=16.8Hz),1.87(3H,s)。Weigh 500.0mg (1.0mmol) of compound 1a into a 100mL round bottom flask, add 50mL of 80% methanol aqueous solution, 7.8g (101.2mmol) of ammonium acetate, and stir overnight at room temperature. After the reaction is finished, add an appropriate amount of water, remove methanol by rotary concentration, extract three times with an equal volume of ethyl acetate, concentrate the ethyl acetate layer, and wash with ethyl acetate:methanol=20:1 through silica gel column chromatography. Compound 3-O-acetyl-epicatechin (2a, 259.0 mg, white powder, yield 78%) was obtained after removal. 1 H NMR (600MHz, DMSO-d 6 ): 9.29 (1H, s), 9.02 (1H, s), 8.92 (1H, s), 8.83 (1H, s), 6.83 (1H, s), 6.69 (1H, d,J=8.4Hz),6.65(1H,d,J=7.8Hz),5.93(1H,s),5.76(1H,s),5.23(1H,br s),4.93(1H,s),2.87 (1H, dd, J = 17.4, 4.2Hz), 2.58 (1H, br d, J = 16.8Hz), 1.87 (3H, s).

化合物2b的合成:Synthesis of compound 2b:

称取4.2g(1.0mol)化合物1b于500mL圆底烧瓶中,加入80%甲醇水溶液80mL,1.0g(11.9mmol)碳酸氢钠,室温搅拌过夜。待反应结束后,加入适量的水,用等体积的乙酸乙酯萃取三次,浓缩乙酸乙酯层,经硅胶柱层析,以乙酸乙酯:甲醇=1:1进行洗脱后得到化合物3-O-乙酰基-表没食子儿茶素(2b,1.05mg,白色粉末,收率40%)。1H NMR(600MHz,DMSO-d6):9.25(1H,s),8.99(1H,s),8.78(1H,s),7.99(1H,s),6.35(2H,s),5.92(1H,d,J=1.2Hz),5.75(1H,d,J=1.8Hz),5.21(1H,br s),4.85(1H,s),2.87(1H,dd,J=17.4,4.8Hz),2.57(1H,br d,J=16.8Hz),1.88(3H,s)。Weigh 4.2g (1.0mol) of compound 1b into a 500mL round bottom flask, add 80mL of 80% methanol aqueous solution, 1.0g (11.9mmol) of sodium bicarbonate, and stir overnight at room temperature. After the reaction was completed, an appropriate amount of water was added, extracted three times with an equal volume of ethyl acetate, the ethyl acetate layer was concentrated, and subjected to silica gel column chromatography, eluted with ethyl acetate:methanol=1:1 to obtain compound 3- O-acetyl-epigallocatechin (2b, 1.05 mg, white powder, yield 40%). 1 H NMR (600MHz, DMSO-d 6 ): 9.25(1H,s), 8.99(1H,s), 8.78(1H,s), 7.99(1H,s), 6.35(2H,s), 5.92(1H ,d,J=1.2Hz),5.75(1H,d,J=1.8Hz),5.21(1H,br s),4.85(1H,s),2.87(1H,dd,J=17.4,4.8Hz), 2.57 (1H, br d, J = 16.8Hz), 1.88 (3H, s).

化合物3a的合成:Synthesis of compound 3a:

称取200.0mg(0.6mmol)化合物2a于100mL圆底烧瓶中,加入干燥的二氯甲烷10mL,816.0mg(12.0mmol)咪唑,40mg(0.33mmol)4-二甲氨基吡啶,在冰浴条件下缓慢滴加含有723.4mg(4.8mmol)叔丁基二甲基氯硅烷的干燥的二氯甲烷溶液10mL。室温搅拌过夜。待反应结束后,加入适量的水,用等体积的二氯甲烷萃取三次,二氯甲烷层溶液用饱和氯化钠洗涤后浓缩,经硅胶柱层析,以石油醚:乙酸乙酯=100:1进行洗脱后得到化合物3-O-乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素(3a,450.0mg,透明油状,收率95%)。1H NMR(600MHz,CDCl3):6.87(1H,s),6.85(1H,d,J=8.4Hz),6.79(1H,d,J=7.8Hz),6.13(1H,brs),5.96(1H,br s),5.37(1H,br s),4.94(1H,s),2.90(1H,dd,J=17.4,4.2Hz),2.83(1H,br d,J=18.0Hz),1.87(3H,s),0.94-0.98(36H,m),0.15-0.21(24H,m)。Weigh 200.0mg (0.6mmol) of compound 2a in a 100mL round-bottomed flask, add 10mL of dry dichloromethane, 816.0mg (12.0mmol) of imidazole, 40mg (0.33mmol) of 4-dimethylaminopyridine, under ice-bath conditions 10 mL of a dry dichloromethane solution containing 723.4 mg (4.8 mmol) of tert-butyldimethylchlorosilane was slowly added dropwise. Stir overnight at room temperature. After the reaction is finished, add an appropriate amount of water, extract three times with an equal volume of dichloromethane, wash the dichloromethane layer solution with saturated sodium chloride, concentrate, and perform silica gel column chromatography with petroleum ether:ethyl acetate=100: 1 was eluted to obtain the compound 3-O-acetyl-5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin (3a, 450.0 mg, transparent oil, yield rate 95%). 1 H NMR (600MHz, CDCl 3 ): 6.87 (1H, s), 6.85 (1H, d, J = 8.4Hz), 6.79 (1H, d, J = 7.8Hz), 6.13 (1H, brs), 5.96 ( 1H,br s),5.37(1H,br s),4.94(1H,s),2.90(1H,dd,J=17.4,4.2Hz),2.83(1H,br d,J=18.0Hz),1.87( 3H, s), 0.94-0.98 (36H, m), 0.15-0.21 (24H, m).

化合物3b的合成:Synthesis of compound 3b:

称取500.0mg(1.4mmol)化合物2b于100mL圆底烧瓶中,加入干燥的二氯甲烷10mL,2.4g(35.3mmol)咪唑,100mg(0.82mmol)4-二甲氨基吡啶,在冰浴条件下缓慢滴加含有2.4g(16.0mmol)叔丁基二甲基氯硅烷的干燥的二氯甲烷溶液10mL。室温搅拌过夜。待反应结束后,加入适量的水,用等体积的二氯甲烷萃取三次,二氯甲烷层溶液用饱和氯化钠洗涤后浓缩,经硅胶柱层析,以石油醚:乙酸乙酯=200:1进行洗脱后得到化合物3-O-乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素(3b,970.0mg,透明油状,收率74%)。1HNMR(600MHz,CDCl3):6.55(2H,s),6.11(1H,d,J=2.4Hz),5.95(1H,d,J=2.4Hz),5.36(1H,m),4.91(1H,br s),2.89(1H,dd,J=17.4,4.8Hz),2.81(1H,dd,J=17.4,3.0Hz),1.86(3H,s),0.90-0.97(45H,m),0.08-0.21(30H,m)。Weigh 500.0mg (1.4mmol) of compound 2b into a 100mL round-bottom flask, add 10mL of dry dichloromethane, 2.4g (35.3mmol) of imidazole, 100mg (0.82mmol) of 4-dimethylaminopyridine, under ice-bath conditions 10 mL of a dry dichloromethane solution containing 2.4 g (16.0 mmol) of tert-butyldimethylchlorosilane was slowly added dropwise. Stir overnight at room temperature. After the reaction is finished, add an appropriate amount of water, extract three times with an equal volume of dichloromethane, wash the dichloromethane layer solution with saturated sodium chloride, concentrate, and perform silica gel column chromatography with petroleum ether:ethyl acetate=200: 1 was eluted to obtain the compound 3-O-acetyl-5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin (3b, 970.0mg, Transparent oil, yield 74%). 1 HNMR (600MHz, CDCl 3 ): 6.55(2H, s), 6.11(1H, d, J=2.4Hz), 5.95(1H, d, J=2.4Hz), 5.36(1H, m), 4.91(1H ,br s),2.89(1H,dd,J=17.4,4.8Hz),2.81(1H,dd,J=17.4,3.0Hz),1.86(3H,s),0.90-0.97(45H,m),0.08 -0.21(30H,m).

化合物4a的合成:Synthesis of compound 4a:

称取100.0mg(0.13mmol)化合物3a于50mL圆底烧瓶中,用100uL干燥的二氯甲烷溶解,再加入干燥的甲醇10mL,50.0mg(0.36mmol)碳酸钾,室温搅拌2小时。待反应结束后,加入适量的水,用等体积的乙酸乙酯萃取三次,乙酸乙酯层溶液用无水硫酸钠干燥并浓缩,经硅胶柱层析,以石油醚:乙酸乙酯=100:1进行洗脱后得到化合物5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素(4a,38.0mg,透明油状,收率40%)。1H NMR(600MHz,CDCl3):6.94(1H,d,J=1.8Hz),6.92(1H,dd,J=8.4,1.8Hz),6.84(1H,d,J=7.8Hz),6.11(1H,d,J=2.4Hz),5.96(1H,d,J=1.8Hz),4.86(1H,s),4.20(1H,br s),2.86(1H,s),2.85(1H,s),0.99(9H,s),0.97(9H,s),0.96(9H,s),0.95(9H,s),0.16-0.22(24H,m)。Weigh 100.0mg (0.13mmol) of compound 3a into a 50mL round bottom flask, dissolve it in 100uL of dry dichloromethane, then add 10mL of dry methanol, 50.0mg (0.36mmol) of potassium carbonate, and stir at room temperature for 2 hours. After the reaction is finished, add an appropriate amount of water, extract three times with an equal volume of ethyl acetate, dry the ethyl acetate layer solution with anhydrous sodium sulfate and concentrate, and perform silica gel column chromatography with petroleum ether:ethyl acetate=100: 1 was eluted to obtain compound 5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin (4a, 38.0 mg, transparent oil, yield 40%). 1 H NMR (600MHz, CDCl 3 ): 6.94 (1H, d, J = 1.8Hz), 6.92 (1H, dd, J = 8.4, 1.8Hz), 6.84 (1H, d, J = 7.8Hz), 6.11 ( 1H,d,J=2.4Hz),5.96(1H,d,J=1.8Hz),4.86(1H,s),4.20(1H,br s),2.86(1H,s),2.85(1H,s) ,0.99(9H,s),0.97(9H,s),0.96(9H,s),0.95(9H,s),0.16-0.22(24H,m).

化合物4b的合成:Synthesis of Compound 4b:

称取970.0mg(1.06mmol)化合物3b于100mL圆底烧瓶中,用100uL干燥的二氯甲烷溶解,再加入干燥的甲醇40mL,200mg(1.44mmol)碳酸钾,室温搅拌2小时。待反应结束后,加入适量的水,用等体积的乙酸乙酯萃取三次,乙酸乙酯层溶液用无水硫酸钠干燥并浓缩,经硅胶柱层析,以石油醚:乙酸乙酯=200:1进行洗脱后得到化合物5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素(4b,353.0mg,透明油状,收率38%)。1H NMR(600MHz,CDCl3):6.59(2H,s),6.09(1H,d,J=1.8Hz),5.95(1H,d,J=2.4Hz),4.82(1H,br s),4.16(1H,m),3.47(1H,s),2.85(1H,dd,J=16.8,4.2Hz),2.80(1H,dd,J=16.8,3.0Hz),0.90-0.99(45H,m),0.10-0.22(30H,m)。Weigh 970.0mg (1.06mmol) of compound 3b into a 100mL round bottom flask, dissolve it with 100uL of dry dichloromethane, then add 40mL of dry methanol, 200mg (1.44mmol) of potassium carbonate, and stir at room temperature for 2 hours. After the reaction is finished, add an appropriate amount of water, extract three times with an equal volume of ethyl acetate, dry the ethyl acetate layer solution with anhydrous sodium sulfate and concentrate, and perform silica gel column chromatography with petroleum ether:ethyl acetate=200: 1 was eluted to obtain compound 5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin (4b, 353.0 mg, transparent oil, yield 38% ). 1 H NMR (600MHz, CDCl 3 ): 6.59 (2H, s), 6.09 (1H, d, J = 1.8Hz), 5.95 (1H, d, J = 2.4Hz), 4.82 (1H, br s), 4.16 (1H,m),3.47(1H,s),2.85(1H,dd,J=16.8,4.2Hz),2.80(1H,dd,J=16.8,3.0Hz),0.90-0.99(45H,m), 0.10-0.22(30H,m).

化合物5a的合成:Synthesis of compound 5a:

称取180.1mg(1.0mmol)咖啡酸于25mL圆底烧瓶中,加入0.3mL干燥的吡啶,0.5mL醋酸酐(5.3mmol),在干燥管保护下室温搅拌过夜。待反应结束后,加入水终止反应,经旋转蒸干后即可得到乙酰化咖啡酸(3,4-O-二乙酰化咖啡酸,250.8mg,收率95%)。1H NMR(600MHz,DMSO-d6):12.47(1H,s)7.66(1H,s),7.63(1H,d,J=8.4Hz),7.57(1H,d,J=16.2Hz),7.31(1H,d,J=8.4Hz),6.53(1H,d,J=16.2Hz),2.29(3H,s),2.29(3H,s)。将反应后的乙酰化咖啡酸转至50mL圆底烧瓶中,加入10mL亚硫酰氯,于90℃加热回流3小时即可得到粗品化合物3,4-O-二乙酰化咖啡酰氯(5a),直接用于下一步反应。Weigh 180.1 mg (1.0 mmol) of caffeic acid into a 25 mL round bottom flask, add 0.3 mL of dry pyridine and 0.5 mL of acetic anhydride (5.3 mmol), and stir overnight at room temperature under the protection of a drying tube. After the reaction was completed, water was added to terminate the reaction, and acetylated caffeic acid (3,4-O-diacetylated caffeic acid, 250.8 mg, yield 95%) was obtained after rotary evaporation to dryness. 1 H NMR (600MHz, DMSO-d 6 ): 12.47 (1H, s) 7.66 (1H, s), 7.63 (1H, d, J = 8.4Hz), 7.57 (1H, d, J = 16.2Hz), 7.31 (1H,d,J=8.4Hz), 6.53(1H,d,J=16.2Hz), 2.29(3H,s), 2.29(3H,s). Transfer the reacted acetylated caffeic acid to a 50 mL round bottom flask, add 10 mL of thionyl chloride, and heat to reflux at 90° C. for 3 hours to obtain the crude compound 3,4-O-diacetylated caffeoyl chloride (5a), directly for the next reaction.

化合物5b的合成:Synthesis of compound 5b:

称取656.0mg(4.0mmol)咖啡酸于25mL圆底烧瓶中,加入0.8mL干燥的吡啶,1.0mL醋酸酐(10.6mmol),在干燥管保护下室温搅拌过夜。待反应结束后,加入水终止反应,经旋转蒸干后即可得到乙酰化香豆酸(4-O-乙酰化香豆酸,774.6mg,收率94%)。1H NMR(600MHz,DMSO-d6):12.36(1H,s)7.73(2H,d,J=9.0Hz),7.60(1H,d,J=14.4Hz),7.18(2H,d,J=8.4Hz),6.50(1H,d,J=16.2Hz),2.28(3H,s)。将反应后的乙酰化香豆酸(251.0mg,1.2mmol)转至25mL圆底烧瓶中,加入3.0mL亚硫酰氯,于90℃加热回流3小时即可得到粗品化合物4-O-乙酰化香豆酰氯(5b),直接用于下一步反应。Weigh 656.0 mg (4.0 mmol) of caffeic acid into a 25 mL round bottom flask, add 0.8 mL of dry pyridine and 1.0 mL of acetic anhydride (10.6 mmol), and stir overnight at room temperature under the protection of a drying tube. After the reaction was completed, water was added to terminate the reaction, and acetylated coumaric acid (4-O-acetylated coumaric acid, 774.6 mg, yield 94%) was obtained after rotary evaporation to dryness. 1 H NMR (600MHz, DMSO-d 6 ): 12.36 (1H, s) 7.73 (2H, d, J = 9.0Hz), 7.60 (1H, d, J = 14.4Hz), 7.18 (2H, d, J = 14.4Hz), 7.18 (2H, d, J = 8.4Hz), 6.50 (1H, d, J = 16.2Hz), 2.28 (3H, s). The reacted acetylated coumaric acid (251.0 mg, 1.2 mmol) was transferred to a 25 mL round bottom flask, 3.0 mL of thionyl chloride was added, and heated to reflux at 90° C. for 3 hours to obtain the crude compound 4-O-acetylated coumaric acid Soybean acid chloride (5b) was directly used in the next reaction.

化合物6a的合成:Synthesis of compound 6a:

称取化合物4a(92.0mg,0.12mmol)于25mL圆底烧瓶中,加入0.2mL干燥的吡啶,2.0mL干燥的二氯甲烷,在冰浴条件下缓慢滴加含有化合物5a(0.18mmol)的干燥二氯甲烷3.0mL。室温反应过夜,加适量的水和等体积的二氯甲烷萃取三次,二氯甲烷层用无水硫酸钠干燥后浓缩,经硅胶柱层析以石油醚:乙酸乙酯=30:1进行洗脱后得到化合物3”,4”-O-二乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素反式咖啡酸酯(6a,95.5mg,油状,收率78%)。1H NMR(600MHz,CDCl3):7.45(1H,d,J=15.6Hz),7.32(1H,dd,J=8.4,1.2Hz),7.26(1H,br s),7.16(1H,d,J=8.4Hz),6.89(1H,d,J=1.8Hz),6.87(1H,br d,J=8.4Hz),6.77(1H,d,J=8.4Hz),6.26(1H,d,J=16.2Hz),6.15(1H,d,J=2.4Hz),5.96(1H,d,J=1.8Hz),5.50(1H,br s),5.00(1H,s),2.96(1H,dd,J=18,4.8Hz),2.90(1H,br d,J=17.4Hz),2.27(6H,s),0.92-0.97(36H,m),0.12-0.21(24H,m)。Weigh compound 4a (92.0mg, 0.12mmol) in a 25mL round bottom flask, add 0.2mL of dry pyridine, 2.0mL of dry dichloromethane, slowly add dropwise the dry solution containing compound 5a (0.18mmol) under ice bath conditions Dichloromethane 3.0 mL. React overnight at room temperature, add an appropriate amount of water and an equal volume of dichloromethane to extract three times, the dichloromethane layer is dried over anhydrous sodium sulfate, concentrated, and eluted by silica gel column chromatography with petroleum ether: ethyl acetate = 30:1 The compound 3", 4"-O-diacetyl-5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin trans-caffeate (6a, 95.5 mg, oily, yield 78%). 1 H NMR (600MHz, CDCl 3 ): 7.45 (1H, d, J = 15.6Hz), 7.32 (1H, dd, J = 8.4, 1.2Hz), 7.26 (1H, br s), 7.16 (1H, d, J=8.4Hz), 6.89(1H,d,J=1.8Hz),6.87(1H,br d,J=8.4Hz),6.77(1H,d,J=8.4Hz),6.26(1H,d,J =16.2Hz),6.15(1H,d,J=2.4Hz),5.96(1H,d,J=1.8Hz),5.50(1H,br s),5.00(1H,s),2.96(1H,dd, J = 18, 4.8Hz), 2.90 (1H, br d, J = 17.4Hz), 2.27 (6H, s), 0.92-0.97 (36H, m), 0.12-0.21 (24H, m).

化合物6b的合成:Synthesis of compound 6b:

称取化合物4a(395.0mg,0.53mmol)于25mL圆底烧瓶中,加入1.5mL干燥的吡啶,3.0mL干燥的二氯甲烷,在冰浴条件下缓慢滴加含有化合物5b(0.80mmol)的干燥二氯甲烷5.0mL。室温反应过夜,加适量的水和等体积的二氯甲烷萃取三次,二氯甲烷层用无水硫酸钠干燥后浓缩,经硅胶柱层析,以石油醚:乙酸乙酯=50:1进行洗脱后得到化合物4”-O-乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素反式香豆酸酯(6b,197.8mg,油状,收率40%)。1H NMR(600MHz,CDCl3):7.49(1H,d,J=15.6Hz),7.44(2H,d,J=9.0Hz),7.07(1H,d,J=9.0Hz),6.91(1H,d,J=1.8Hz),6.86(1H,dd,J=8.4,2.4Hz),6.77(1H,d,J=8.4Hz),6.26(1H,d,J=16.2Hz),6.16(1H,d,J=1.8Hz),5.97(1H,d,J=2.4Hz),5.52(1H,br s),5.01(1H,s),2.97(1H,dd,J=17.4,4.2Hz),2.90(1H,dd,J=16.8,3.0Hz),2.28(3H,s),0.92-0.97(36H,m),0.12-0.21(24H,m)。Weigh compound 4a (395.0mg, 0.53mmol) in a 25mL round bottom flask, add 1.5mL of dry pyridine, 3.0mL of dry dichloromethane, slowly add dropwise the dry solution containing compound 5b (0.80mmol) under ice bath conditions Dichloromethane 5.0 mL. React overnight at room temperature, add an appropriate amount of water and an equal volume of dichloromethane to extract three times, the dichloromethane layer was dried over anhydrous sodium sulfate, concentrated, and subjected to silica gel column chromatography, washed with petroleum ether: ethyl acetate = 50:1 After removal, the compound 4"-O-acetyl-5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin trans-coumarate (6b, 197.8mg, Oily, yield 40%). 1 H NMR (600MHz, CDCl 3 ): 7.49 (1H, d, J = 15.6Hz), 7.44 (2H, d, J = 9.0Hz), 7.07 (1H, d, J = 9.0Hz), 6.91(1H,d,J=1.8Hz), 6.86(1H,dd,J=8.4,2.4Hz), 6.77(1H,d,J=8.4Hz), 6.26(1H,d,J= 16.2Hz), 6.16(1H,d,J=1.8Hz), 5.97(1H,d,J=2.4Hz), 5.52(1H,br s), 5.01(1H,s), 2.97(1H,dd,J = 17.4, 4.2Hz), 2.90 (1H, dd, J = 16.8, 3.0Hz), 2.28 (3H, s), 0.92-0.97 (36H, m), 0.12-0.21 (24H, m).

化合物6c的合成:Synthesis of compound 6c:

称取化合物4b(500.0mg,0.57mmol)于100mL圆底烧瓶中,加入2.0mL干燥的吡啶,5.0mL干燥的二氯甲烷,在冰浴条件下缓慢滴加含有化合物5a(1.9mmol)的干燥二氯甲烷8.0mL。室温反应过夜,加适量的水和等体积的二氯甲烷萃取三次,二氯甲烷层用无水硫酸钠干燥后浓缩,经硅胶柱层析以石油醚:乙酸乙酯=30:1进行洗脱后得到化合物3”,4”-O-二乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素反式咖啡酸酯(6c,172.1mg,油状,收率70%)。1H NMR(600MHz,CDCl3):7.44(1H,d,J=16.2Hz),7.29(1H,dd,J=8.4,1.8Hz),7.24(1H,s),7.16(1H,d,J=8.4Hz),6.56(2H,s),6.23(1H,d,J=16.2Hz),6.14(1H,d,J=2.4Hz),5.95(1H,d,J=2.4Hz),5.49(1H,m),4.97(1H,s),2.95(1H,dd,J=17.4,4.8Hz),2.87(1H,dd,J=17.4,3.6Hz),2.26(6H,s),0.86-0.97(45H,m),0.04-0.21(30H,m)。Weigh compound 4b (500.0mg, 0.57mmol) in a 100mL round bottom flask, add 2.0mL of dry pyridine, 5.0mL of dry dichloromethane, slowly add dropwise the dry solution containing compound 5a (1.9mmol) under ice bath conditions Dichloromethane 8.0 mL. React overnight at room temperature, add an appropriate amount of water and an equal volume of dichloromethane to extract three times, the dichloromethane layer is dried over anhydrous sodium sulfate, concentrated, and eluted by silica gel column chromatography with petroleum ether: ethyl acetate = 30:1 Compound 3",4"-O-diacetyl-5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin trans-caffeate (6c, 172.1 mg, oil, yield 70%). 1 H NMR (600MHz, CDCl 3 ): 7.44(1H,d,J=16.2Hz),7.29(1H,dd,J=8.4,1.8Hz),7.24(1H,s),7.16(1H,d,J =8.4Hz),6.56(2H,s),6.23(1H,d,J=16.2Hz),6.14(1H,d,J=2.4Hz),5.95(1H,d,J=2.4Hz),5.49( 1H,m),4.97(1H,s),2.95(1H,dd,J=17.4,4.8Hz),2.87(1H,dd,J=17.4,3.6Hz),2.26(6H,s),0.86-0.97 (45H,m),0.04-0.21(30H,m).

化合物6d的合成:Synthesis of compound 6d:

称取化合物4b(370.0mg,0.42mmol)于100mL圆底烧瓶中,加入2.0mL干燥的吡啶,5.0mL干燥的二氯甲烷,在冰浴条件下缓慢滴加含有化合物5b(1.5mmol)的干燥二氯甲烷7.0mL。室温反应过夜,加适量的水和等体积的二氯甲烷萃取三次,二氯甲烷层用无水硫酸钠干燥后浓缩,经硅胶柱层析以石油醚:乙酸乙酯=50:1进行洗脱后得到化合物4”-O-乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素反式香豆酸酯(6d,280.0mg,油状,收率62%)。1H NMR(600MHz,CDCl3):7.48(1H,d,J=16.2Hz),7.43(2H,d,J=9.0Hz),7.07(2H,d,J=8.4Hz),6.57(2H,s),6.24(1H,d,J=15.6Hz),6.15(1H,d,J=1.8Hz),5.96(1H,d,J=2.4Hz),5.50(1H,m),4.97(1H,s),2.95(1H,dd,J=17.4,4.8Hz),2.88(1H,dd,J=17.4,3.0Hz),2.28(3H,s),0.86-0.97(45H,m),0.04-0.20(30H,m)。Weigh compound 4b (370.0mg, 0.42mmol) in a 100mL round bottom flask, add 2.0mL of dry pyridine, 5.0mL of dry dichloromethane, slowly add dropwise the dry solution containing compound 5b (1.5mmol) under ice bath conditions Dichloromethane 7.0 mL. React overnight at room temperature, add an appropriate amount of water and an equal volume of dichloromethane to extract three times, the dichloromethane layer is dried over anhydrous sodium sulfate, concentrated, and eluted by silica gel column chromatography with petroleum ether: ethyl acetate = 50:1 The compound 4"-O-acetyl-5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin trans-coumarate (6d, 280.0 mg, oil, yield 62%). 1 H NMR (600MHz, CDCl 3 ): 7.48 ( 1 H, d, J = 16.2 Hz), 7.43 (2H, d, J = 9.0 Hz), 7.07 (2H, d,J=8.4Hz),6.57(2H,s),6.24(1H,d,J=15.6Hz),6.15(1H,d,J=1.8Hz),5.96(1H,d,J=2.4Hz) ,5.50(1H,m),4.97(1H,s),2.95(1H,dd,J=17.4,4.8Hz),2.88(1H,dd,J=17.4,3.0Hz),2.28(3H,s), 0.86-0.97(45H,m),0.04-0.20(30H,m).

化合物7a合成:Compound 7a synthesis:

称取化合物6b(163.0mg,0.17mmol)于25mL圆底烧瓶中,加入氟氢化钾(136.0mg,1.7mmol),再加入6.0mL干燥的甲醇,室温下反应3.5小时。待反应结束后加入适量的水,用等体积的乙酸乙酯萃取三次。乙酸乙酯层用无水硫酸钠干燥后浓缩,经硅胶柱层析以石油醚:乙酸乙酯=1:1进行洗脱后得到化合物4”-O-乙酰基-表儿茶素反式香豆酸酯(7a,70.9mg,白色粉末,收率85%)。1H NMR(600MHz,DMSO-d6):9.27(1H,s),9.01(1H,s),8.82(1H,s),8.77(1H,s),7.73(2H,d,J=8.4Hz),7.51(1H,dd,J=16.2Hz),7.15(2H,d,J=8.4Hz),6.89(1H,d,J=1.8Hz),6.71(1H,dd,J=8.4,1.8Hz),6.67(1H,d,J=8.4Hz),6.48(1H,d,J=16.2Hz),5.94(1H,d,J=1.8Hz),5.81(1H,d,J=1.8Hz),5.36(1H,br s),5.02(1H,s),2.95(1H,dd,J=17.4,4.8Hz),2.68(1H,br d,J=16.8Hz),2.27(3H,s)。Weigh compound 6b (163.0 mg, 0.17 mmol) into a 25 mL round bottom flask, add potassium bifluoride (136.0 mg, 1.7 mmol), then add 6.0 mL of dry methanol, and react at room temperature for 3.5 hours. After the reaction was completed, an appropriate amount of water was added, and extracted three times with an equal volume of ethyl acetate. The ethyl acetate layer was dried over anhydrous sodium sulfate and concentrated, and eluted with petroleum ether: ethyl acetate = 1:1 through silica gel column chromatography to obtain compound 4"-O-acetyl-epicatechin trans-aroma Soyate (7a, 70.9mg, white powder, yield 85%). 1 H NMR (600MHz, DMSO-d 6 ): 9.27(1H,s), 9.01(1H,s), 8.82(1H,s) ,8.77(1H,s),7.73(2H,d,J=8.4Hz),7.51(1H,dd,J=16.2Hz),7.15(2H,d,J=8.4Hz),6.89(1H,d, J=1.8Hz),6.71(1H,dd,J=8.4,1.8Hz),6.67(1H,d,J=8.4Hz),6.48(1H,d,J=16.2Hz),5.94(1H,d, J=1.8Hz), 5.81(1H,d,J=1.8Hz),5.36(1H,br s),5.02(1H,s),2.95(1H,dd,J=17.4,4.8Hz),2.68(1H ,br d,J=16.8Hz), 2.27(3H,s).

化合物7b合成:Compound 7b synthesis:

称取化合物6d(130.0mg,0.12mmol)于25mL圆底烧瓶中,加入氟氢化钾(476.0mg,6.1mmol),再加入8.0mL干燥的甲醇,50℃下反应6小时。反应产物浓缩后经LH-20凝胶柱层析,以甲醇洗脱后得到化合物4”-O-乙酰基-表没食子儿茶素反式香豆酸酯(7b,36.0mg,白色粉末,收率60%)。1H NMR(600MHz,DMSO-d6):9.29(1H,s),9.03(1H,s),8.76(1H,s),8.00(1H,s),7.72(2H,d,J=8.4Hz),7.51(1H,dd,J=16.2Hz),7.15(2H,d,J=9.0Hz),6.46(1H,d,J=16.2Hz),6.40(2H,s),5.94(1H,d,J=2.4Hz),5.79(1H,d,J=2.4Hz),5.34(1H,brs),4.95(1H,s),2.94(1H,dd,J=17.4,4.8Hz),2.67(1H,br d,J=16.2Hz),2.26(3H,s)。Weigh compound 6d (130.0mg, 0.12mmol) into a 25mL round bottom flask, add potassium bifluoride (476.0mg, 6.1mmol), then add 8.0mL dry methanol, and react at 50°C for 6 hours. After the reaction product was concentrated, it was subjected to LH-20 gel column chromatography and eluted with methanol to obtain the compound 4"-O-acetyl-epigallocatechin trans-coumarate (7b, 36.0mg, white powder, yield 60% yield). 1 H NMR (600MHz, DMSO-d 6 ): 9.29 (1H, s), 9.03 (1H, s), 8.76 (1H, s), 8.00 (1H, s), 7.72 (2H, d ,J=8.4Hz),7.51(1H,dd,J=16.2Hz),7.15(2H,d,J=9.0Hz),6.46(1H,d,J=16.2Hz),6.40(2H,s), 5.94(1H,d,J=2.4Hz),5.79(1H,d,J=2.4Hz),5.34(1H,brs),4.95(1H,s),2.94(1H,dd,J=17.4,4.8Hz ), 2.67 (1H, br d, J = 16.2Hz), 2.26 (3H, s).

化合物8a合成:Synthesis of compound 8a:

称取6a(164.0mg,0.16mmol)于25mL圆底烧瓶中,加入氟氢化钾(28.0mg,1.64mmol),再加入6.0mL干燥的甲醇,50℃下反应6小时。反应产物经LH-20凝胶柱层析,以甲醇洗脱后得到化合物表儿茶素反式咖啡酸酯(8a,52.0mg,白色粉末,收率70%)。1H NMR(600MHz,DMSO-d6):7.32(1H,d,J=16.2Hz),6.98(1H,s),6.95(1H,dd,J=6.6,1.8Hz),6.88(1H,s),6.73(1H,d,J=7.8Hz),6.70(1H,dd,J=8.4,1.2Hz),6.67(1H,dd,J=7.8Hz),6.12(1H,d,J=15.6Hz),5.94(1H,d,J=1.8Hz),5.81(1H,d,J=1.8Hz),5.31(1H,br s),5.01(1H,s),2.92(1H,dd,J=17.4,4.8Hz),2.67(1H,br d,J=16.2Hz)。HR-ESI-MS(负离子):m/z451.1040[M-H]-Weigh 6a (164.0 mg, 0.16 mmol) into a 25 mL round bottom flask, add potassium bifluoride (28.0 mg, 1.64 mmol), then add 6.0 mL of dry methanol, and react at 50° C. for 6 hours. The reaction product was subjected to LH-20 gel column chromatography and eluted with methanol to obtain the compound epicatechin trans-caffeate (8a, 52.0 mg, white powder, yield 70%). 1 H NMR (600MHz, DMSO-d 6 ): 7.32 (1H, d, J = 16.2Hz), 6.98 (1H, s), 6.95 (1H, dd, J = 6.6, 1.8Hz), 6.88 (1H, s ),6.73(1H,d,J=7.8Hz),6.70(1H,dd,J=8.4,1.2Hz),6.67(1H,dd,J=7.8Hz),6.12(1H,d,J=15.6Hz ),5.94(1H,d,J=1.8Hz),5.81(1H,d,J=1.8Hz),5.31(1H,br s),5.01(1H,s),2.92(1H,dd,J=17.4 , 4.8 Hz), 2.67 (1H, br d, J = 16.2 Hz). HR-ESI-MS (negative ion): m/z 451.1040[MH] - .

化合物8b的合成:Synthesis of compound 8b:

称取7a(50.0mg,0.1mmol)于10mL圆底烧瓶中,加醋酸铵(450.0mg,5.8mmol),加入80%甲醇水溶液2.0mL,室温反应5.5小时。反应产物经LH-20凝胶柱层析,以甲醇洗脱后得到化合物表儿茶素反式香豆酸酯(8b,45.6mg,白色粉末,收率88%)。1H NMR(600MHz,DMSO-d6):7.50(2H,d,J=8.4Hz),7.41(1H,d,J=15.6Hz),6.88(1H,d,J=1.8Hz),6.75(2H,d,J=9.0Hz),6.70(1H,dd,J=8.4,1.2Hz),6.67(1H,d,J=7.8Hz),6.24(1H,d,J=15.6Hz),5.93(1H,d,J=1.8Hz),5.80(1H,d,J=1.8Hz),5.32(1H,br s),5.01(1H,s),2.92(1H,dd,J=17.4,4.8Hz),2.66(1H,br d,J=16.2Hz)。HR-ESI-MS(负离子):m/z435.1088[M-H]-Weigh 7a (50.0 mg, 0.1 mmol) into a 10 mL round bottom flask, add ammonium acetate (450.0 mg, 5.8 mmol), add 2.0 mL of 80% methanol aqueous solution, and react at room temperature for 5.5 hours. The reaction product was subjected to LH-20 gel column chromatography and eluted with methanol to obtain the compound epicatechin trans-coumarate (8b, 45.6 mg, white powder, yield 88%). 1H NMR (600MHz, DMSO-d 6 ): 7.50 (2H, d, J = 8.4Hz), 7.41 (1H, d, J = 15.6Hz), 6.88 (1H, d, J = 1.8Hz), 6.75 (2H ,d,J=9.0Hz),6.70(1H,dd,J=8.4,1.2Hz),6.67(1H,d,J=7.8Hz),6.24(1H,d,J=15.6Hz),5.93(1H ,d,J=1.8Hz),5.80(1H,d,J=1.8Hz),5.32(1H,br s),5.01(1H,s),2.92(1H,dd,J=17.4,4.8Hz), 2.66 (1H,brd,J=16.2Hz). HR-ESI-MS (negative ion): m/z 435.1088[MH] - .

化合物8c的合成:Synthesis of Compound 8c:

称取6c(60.0mg,0.05mmol)于25mL圆底烧瓶中,加入氟氢化钾(200.0mg,2.56mmol),再加入5.0mL干燥的甲醇,50℃下反应6小时。反应产物经LH-20凝胶柱层析,以甲醇洗脱后得到化合物表没食子儿茶素反式咖啡酸酯(8c,15.0mg,白色粉末,收率60%)。1H NMR(600MHz,DMSO-d6):7.33(1H,d,J=16.8Hz),6.98(1H,d,J=1.8Hz),6.96(1H,dd,J=8.4,1.8Hz),6.72(1H,d,J=8.4Hz),6.39(2H,s),6.09(1H,d,J=16.2Hz),5.93(1H,d,J=1.8Hz),5.79(1H,d,J=2.4Hz),5.28(1H,br s),4.93(1H,s),2.90(1H,dd,J=17.4,4.8Hz),2.64(1H,br d,J=16.2Hz)。HR-ESI-MS(负离子):m/z 451.1033[M-H]-Weigh 6c (60.0 mg, 0.05 mmol) into a 25 mL round bottom flask, add potassium bifluoride (200.0 mg, 2.56 mmol), then add 5.0 mL of dry methanol, and react at 50° C. for 6 hours. The reaction product was subjected to LH-20 gel column chromatography and eluted with methanol to obtain the compound epigallocatechin trans-caffeate (8c, 15.0 mg, white powder, yield 60%). 1 H NMR (600MHz, DMSO-d 6 ): 7.33 (1H, d, J = 16.8Hz), 6.98 (1H, d, J = 1.8Hz), 6.96 (1H, dd, J = 8.4, 1.8Hz), 6.72(1H,d,J=8.4Hz),6.39(2H,s),6.09(1H,d,J=16.2Hz),5.93(1H,d,J=1.8Hz),5.79(1H,d,J = 2.4Hz), 5.28 (1H, br s), 4.93 (1H, s), 2.90 (1H, dd, J = 17.4, 4.8Hz), 2.64 (1H, br d, J = 16.2Hz). HR-ESI-MS (negative ion): m/z 451.1033 [MH] - .

化合物8d的合成:Synthesis of compound 8d:

称取7b(36.0mg,0.07mmol)于10mL圆底烧瓶中,加醋酸铵(460.0mg,6.0mmol),加入80%甲醇水溶液2.0mL,室温反应5小时。反应产物经LH-20凝胶柱层析,以甲醇洗脱后得到化合物表没食子儿茶素反式香豆酸酯(8d,18.1mg,白色粉末,收率55%)。1H NMR(600MHz,DMSO-d6):7.49(2H,d,J=8.4Hz),7.41(1H,d,J=15.6Hz),6.75(2H,d,J=8.4Hz),6.39(2H,s),6.22(1H,d,J=15.6Hz),5.93(1H,d,J=2.4Hz),5.79(1H,d,J=1.8Hz),5.30(1H,br s),4.93(1H,s),2.91(1H,dd,J=17.4,4.8Hz),2.65(1H,br d,J=16.2Hz)。HR-ESI-MS(负离子):m/z467.0979[M-H]-Weigh 7b (36.0 mg, 0.07 mmol) into a 10 mL round bottom flask, add ammonium acetate (460.0 mg, 6.0 mmol), add 2.0 mL of 80% methanol aqueous solution, and react at room temperature for 5 hours. The reaction product was subjected to LH-20 gel column chromatography and eluted with methanol to obtain the compound epigallocatechin trans-coumarate (8d, 18.1 mg, white powder, yield 55%). 1 H NMR (600MHz, DMSO-d 6 ): 7.49 (2H, d, J = 8.4Hz), 7.41 (1H, d, J = 15.6Hz), 6.75 (2H, d, J = 8.4Hz), 6.39 ( 2H, s), 6.22 (1H, d, J = 15.6Hz), 5.93 (1H, d, J = 2.4Hz), 5.79 (1H, d, J = 1.8Hz), 5.30 (1H, br s), 4.93 (1H, s), 2.91 (1H, dd, J = 17.4, 4.8Hz), 2.65 (1H, br d, J = 16.2Hz). HR-ESI-MS (negative ion): m/z 467.0979[MH] - .

实施例2Example 2

将实施例1中制备的表儿茶素反式香豆酸酯、表儿茶素反式咖啡酸酯、表没食子儿茶素反式香豆酸酯与表没食子儿茶素反式咖啡酸酯四种羟基肉桂酰酯型儿茶素进行体外抑制α-葡萄糖苷酶活性实验。The epicatechin trans-coumarate, epicatechin trans-caffeate, epigallocatechin trans-coumarate and epigallocatechin trans-caffeate prepared in Example 1 Four hydroxycinnamoyl catechins were tested for their inhibition of α-glucosidase activity in vitro.

2.1实验材料和试剂2.1 Experimental materials and reagents

阿卡波糖、磷酸钾缓冲液(PPBS,10mM,PH为6.9)、α-葡萄糖苷酶(0.1U·mL-1)、4-硝基苯基-α-D-吡喃葡萄糖苷(pNPG,2.5mM)、二甲基亚砜(DMSO)Acarbose, potassium phosphate buffer (PPBS, 10mM, pH 6.9), α-glucosidase (0.1U·mL -1 ), 4-nitrophenyl-α-D-glucopyranoside (pNPG , 2.5mM), dimethyl sulfoxide (DMSO)

2.2实验方法及结果2.2 Experimental methods and results

在96孔板中加入60μL的α-葡萄糖苷酶溶液,分别加入不同浓度梯度的四种羟基肉桂酰酯型儿茶素60μL,在37℃预孵化10min后,分别添加60μL的pNPG溶液,继续在37℃孵化20min后置于酶标仪(25℃),在波长405nm的可见光下,记录反应液的A值。所有样品均重复3次,记为A样品。用60μL的PPBS代替α-葡萄糖苷酶,记为A空白(重复3次),做空白调零。用60μL的PPBS代替样品溶液,记为A测试。用120μL的PPBS代替样品溶液和α-葡萄糖苷酶,记为A对照(重复3次)。Add 60 μL of α-glucosidase solution to a 96-well plate, add 60 μL of four hydroxycinnamoyl ester catechins with different concentration gradients, and pre-incubate at 37°C for 10 minutes, add 60 μL of pNPG solution respectively, and continue to After incubating at 37°C for 20 minutes, place it in a microplate reader (25°C), and record the A value of the reaction solution under visible light with a wavelength of 405nm. All samples were repeated 3 times, which were recorded as A samples. Replace α-glucosidase with 60 μL of PPBS, record it as A blank (repeat 3 times), and make blank zero adjustment. Replace the sample solution with 60 μL of PPBS, denoted as A test. Replace the sample solution and α-glucosidase with 120 μL of PPBS, and record it as control A (repeat 3 times).

对乙酰胆碱酯酶的酶抑制率按以下公式计算:The enzyme inhibition rate to acetylcholinesterase was calculated according to the following formula:

抑制率(%)=(1-(A样品-A空白)/(A测试-A对照))×100%。Inhibition rate (%)=(1-(A sample-A blank)/(A test-A control))×100%.

以酶的相对活力对抑制剂浓度作图,根据抑制曲线即可计算出四种羟基肉桂酰酯型儿茶素与α-葡萄糖苷酶作用的IC50值。所测得的结果如下表所示:The relative activity of the enzyme was plotted against the concentration of the inhibitor, and the IC 50 value of the four hydroxycinnamoyl catechins interacting with α-glucosidase could be calculated according to the inhibition curve. The measured results are shown in the table below:

Figure BDA0002373026030000161
Figure BDA0002373026030000161

注:阳性对照药物——阿卡波糖Note: positive control drug - acarbose

由表中的结果可知,本发明制备的四种羟基肉桂酰酯型儿茶素:表儿茶素反式香豆酸酯、表儿茶素反式咖啡酸酯、表没食子儿茶素反式香豆酸酯与表没食子儿茶素反式咖啡酸酯对α-葡萄糖苷酶均有强的抑制作用,可应用于制备降血糖药物,具有广阔的应用前景。As can be seen from the results in the table, four kinds of hydroxycinnamoyl ester type catechins prepared by the present invention: epicatechin trans coumarate, epicatechin trans caffeate, epigallocatechin trans Both coumarate and epigallocatechin trans-caffeate have a strong inhibitory effect on α-glucosidase, and can be used in the preparation of hypoglycemic drugs and have broad application prospects.

应当理解本文所述的例子和实施方式仅为了说明,并不用于限制本发明,本领域技术人员可根据它做出各种修改或变化,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。It should be understood that the examples and implementations described herein are for illustration only, and are not intended to limit the present invention, and those skilled in the art can make various modifications or changes based on it, and within the spirit and principles of the present invention, any Modifications, equivalent replacements, improvements, etc., should all be included within the protection scope of the present invention.

Claims (3)

1.一类羟基肉桂酰酯型儿茶素的制备方法,该类羟基肉桂酰酯型儿茶素包括4种儿茶素,该4种儿茶素的名称分别为表儿茶素反式香豆酸酯即(–)-epicatechin 3-O-p-coumaroate、表儿茶素反式咖啡酸酯即(–)-epicatechin3-O-caffeoate、表没食子儿茶素反式香豆酸酯即(–)-epigallocatechin1. The preparation method of a class of hydroxycinnamoyl ester catechins, the hydroxycinnamoyl ester catechins include 4 kinds of catechins, the names of these 4 kinds of catechins are respectively epicatechin trans-flavored Soyate is (–)-epicatechin 3-O-p-coumaroate, epicatechin trans-caffeoate is (–)-epicatechin3-O-caffeoate, epigallocatechin trans-coumarate is (–) - epigallocatechin 3-O-p-coumaroate、表没食子儿茶素反式咖啡酸酯即(–)-epigallocatechin3-O-p-coumaroate, epigallocatechin trans-caffeate (–)-epigallocatechin 3-O-caffeoate,其结构式分别如式Ⅰ、式Ⅱ、式Ⅲ和式Ⅳ所示,3-O-caffeoate, whose structural formulas are shown in formula Ⅰ, formula Ⅱ, formula Ⅲ and formula Ⅳ respectively,
Figure FDA0004059160290000011
Figure FDA0004059160290000011
其特征在于,该类羟基肉桂酰酯型儿茶素的制备方法包括如下步骤:It is characterized in that the preparation method of the hydroxycinnamoyl catechins comprises the following steps: S1、以表儿茶素即EC为原料,通过全乙酰化、脱去酚羟基上的乙酰基、酚羟基硅烷化及脱去3位乙酰基四个反应后制得5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素;S1. Using epicatechin (EC) as a raw material, 5,7,3', 4'-O-tetra-tert-butyldimethylsilyl-epicatechin; 以表没食子儿茶素即EGC为原料,通过全乙酰化、脱去酚羟基上的乙酰基、酚羟基硅烷化及脱去3位乙酰基四个反应后制得5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素;Using epigallocatechin (EGC) as a raw material, 5,7,3',4 is prepared by four reactions: full acetylation, removal of acetyl group on phenolic hydroxyl group, silylation of phenolic hydroxyl group and removal of 3-position acetyl group. ',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin; S2、制备3”,4”-O-二乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素反式咖啡酸酯;S2. Preparation of 3”, 4”-O-diacetyl-5,7,3’,4’-O-tetra-tert-butyldimethylsilyl-epicatechin trans-caffeate; 称取92.0mg步骤S1制得的5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素于25mL圆底烧瓶中,加入0.2mL干燥的吡啶,2.0mL干燥的二氯甲烷,在冰浴条件下缓慢滴加含有0.18mmol的3,4-O-二乙酰化咖啡酰氯的干燥二氯甲烷3.0mL,室温反应过夜,加适量的水和等体积的二氯甲烷萃取三次,二氯甲烷层用无水硫酸钠干燥后浓缩,经硅胶柱层析以石油醚:乙酸乙酯=30:1进行洗脱后得到3”,4”-O-二乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素反式咖啡酸酯;Weigh 92.0 mg of 5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin prepared in step S1 into a 25 mL round bottom flask, add 0.2 mL of dry pyridine, 2.0 mL of dry dichloromethane, slowly add 3.0 mL of dry dichloromethane containing 0.18 mmol of 3,4-O-diacetylated caffeoyl chloride dropwise under ice bath conditions, react overnight at room temperature, add appropriate amount of water and an equal volume of Dichloromethane was extracted three times, and the dichloromethane layer was dried over anhydrous sodium sulfate and concentrated. After silica gel column chromatography was eluted with petroleum ether: ethyl acetate = 30:1 to obtain 3”, 4”-O-diacetyl -5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin trans-caffeate; S3、制备4”-O-乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素反式香豆酸酯;S3. Preparation of 4"-O-acetyl-5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin trans-coumarate; 称取395.0mg步骤S1制得的5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素于25mL圆底烧瓶中,加入1.5mL干燥的吡啶,3.0mL干燥的二氯甲烷,在冰浴条件下缓慢滴加含有0.80mmol的4-O-乙酰化香豆酰氯的干燥二氯甲烷5.0mL,室温反应过夜,加适量的水和等体积的二氯甲烷萃取三次,二氯甲烷层用无水硫酸钠干燥后浓缩,经硅胶柱层析,以石油醚:乙酸乙酯=50:1进行洗脱后得到4”-O-乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素反式香豆酸酯;Weigh 395.0 mg of 5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin prepared in step S1 into a 25 mL round bottom flask, add 1.5 mL of dry pyridine, 3.0 mL of dry dichloromethane, slowly add 5.0 mL of dry dichloromethane containing 0.80 mmol of 4-O-acetylated coumaryl chloride dropwise under ice bath conditions, react overnight at room temperature, add appropriate amount of water and an equal volume of dichloromethane Methane was extracted three times, the dichloromethane layer was dried over anhydrous sodium sulfate and concentrated, and silica gel column chromatography was eluted with petroleum ether: ethyl acetate = 50:1 to obtain 4”-O-acetyl-5,7 ,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin trans-coumarate; S4、制备3”,4”-O-二乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素反式咖啡酸酯;S4. Preparation of 3", 4"-O-diacetyl-5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin trans-caffeate ; 称取500.0mg步骤S1制得的5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素于100mL圆底烧瓶中,加入2.0mL干燥的吡啶,5.0mL干燥的二氯甲烷,在冰浴条件下缓慢滴加含有1.9mmol的3,4-O-二乙酰化咖啡酰氯的干燥二氯甲烷8.0mL,室温反应过夜,加适量的水和等体积的二氯甲烷萃取三次,二氯甲烷层用无水硫酸钠干燥后浓缩,经硅胶柱层析以石油醚:乙酸乙酯=30:1进行洗脱后得到3”,4”-O-二乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素反式咖啡酸酯;Weigh 500.0mg of 5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin prepared in step S1 into a 100mL round bottom flask, add 2.0mL to dry Pyridine, 5.0 mL of dry dichloromethane, slowly add 8.0 mL of dry dichloromethane containing 1.9 mmol of 3,4-O-diacetylated caffeoyl chloride dropwise under ice bath conditions, react overnight at room temperature, add appropriate amount of water and an equal volume of dichloromethane for three extractions, the dichloromethane layer was dried over anhydrous sodium sulfate and concentrated, and eluted with petroleum ether: ethyl acetate = 30:1 by silica gel column chromatography to obtain 3”, 4”- O-diacetyl-5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin trans-caffeate; S5、制备4”-O-乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素反式香豆酸酯;S5. Preparation of 4"-O-acetyl-5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin trans-coumarate; 称取370.0mg步骤S1制得的5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素于100mL圆底烧瓶中,加入2.0mL干燥的吡啶,5.0mL干燥的二氯甲烷,在冰浴条件下缓慢滴加含有1.5mmol的4-O-乙酰化香豆酰氯的干燥二氯甲烷7.0mL,室温反应过夜,加适量的水和等体积的二氯甲烷萃取三次,二氯甲烷层用无水硫酸钠干燥后浓缩,经硅胶柱层析以石油醚:乙酸乙酯=50:1进行洗脱后得到4”-O-乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素反式香豆酸酯;Weigh 370.0mg of 5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin prepared in step S1 into a 100mL round bottom flask, add 2.0mL to dry Pyridine, 5.0 mL of dry dichloromethane, slowly add 7.0 mL of dry dichloromethane containing 1.5 mmol of 4-O-acetylated coumaryl chloride dropwise under ice bath conditions, react overnight at room temperature, add appropriate amount of water and etc. The volume of dichloromethane was extracted three times, the dichloromethane layer was dried with anhydrous sodium sulfate and then concentrated, and 4”-O-acetyl- 5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin trans-coumarate; S6、制备表儿茶素反式咖啡酸酯;S6, preparing epicatechin trans-caffeate; 称取164.0mg步骤S2制得的3”,4”-O-二乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素反式咖啡酸酯于25mL圆底烧瓶中,加入28.0mg氟氢化钾,再加入6.0mL干燥的甲醇,50℃下反应6小时,反应产物经LH-20凝胶柱层析,以甲醇洗脱后得到表儿茶素反式咖啡酸酯;Weigh 164.0 mg of 3",4"-O-diacetyl-5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin trans coffee prepared in step S2 In a 25mL round-bottomed flask, add 28.0mg potassium bifluoride, then add 6.0mL dry methanol, and react at 50°C for 6 hours. The reaction product is eluted with methanol to obtain the following table: Catechin trans caffeate; S7、制备表没食子儿茶素反式咖啡酸酯;S7, preparing epigallocatechin trans-caffeate; 称取60.0mg步骤S4制得的3”,4”-O-二乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素反式咖啡酸酯于25mL圆底烧瓶中,加入200.0mg氟氢化钾,再加入5.0mL干燥的甲醇,50℃下反应6小时,反应产物经LH-20凝胶柱层析,以甲醇洗脱后得到表没食子儿茶素反式咖啡酸酯;Weigh 60.0 mg of 3",4"-O-diacetyl-5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin prepared in step S4 Add 200.0mg of potassium bifluoride to a 25mL round bottom flask, then add 5.0mL of dry methanol, and react at 50°C for 6 hours. The reaction product is subjected to LH-20 gel column chromatography and washed with methanol. After taking off, epigallocatechin trans-caffeate is obtained; S8、制备表儿茶素反式香豆酸酯;S8, preparing epicatechin trans-coumarate; 称取163.0mg步骤S3制得的4”-O-乙酰基-5,7,3’,4’-O-四叔丁基二甲基硅基-表儿茶素反式香豆酸酯于25mL圆底烧瓶中,加入136.0mg氟氢化钾,再加入6.0mL干燥的甲醇,室温下反应3.5小时,待反应结束后加入适量的水,用等体积的乙酸乙酯萃取三次,乙酸乙酯层用无水硫酸钠干燥后浓缩,经硅胶柱层析以石油醚:乙酸乙酯=1:1进行洗脱后得到4”-O-乙酰基-表儿茶素反式香豆酸酯;Weigh 163.0 mg of 4"-O-acetyl-5,7,3',4'-O-tetra-tert-butyldimethylsilyl-epicatechin trans-coumarate prepared in step S3 in In a 25mL round bottom flask, add 136.0mg potassium bifluoride, then add 6.0mL dry methanol, react at room temperature for 3.5 hours, add an appropriate amount of water after the reaction is completed, extract three times with an equal volume of ethyl acetate, and the ethyl acetate layer After drying with anhydrous sodium sulfate and concentrating, 4"-O-acetyl-epicatechin trans-coumarate was obtained after silica gel column chromatography was eluted with petroleum ether: ethyl acetate = 1:1; 称取50.0mg的4”-O-乙酰基-表儿茶素反式香豆酸酯于10mL圆底烧瓶中,加450.0mg醋酸铵,加入体积分数为80%甲醇水溶液2.0mL,室温反应5.5小时,反应产物经LH-20凝胶柱层析,以甲醇洗脱后得到表儿茶素反式香豆酸酯;Weigh 50.0 mg of 4”-O-acetyl-epicatechin trans-coumarate into a 10 mL round bottom flask, add 450.0 mg of ammonium acetate, add 2.0 mL of 80% methanol aqueous solution, and react at room temperature for 5.5 hour, the reaction product was subjected to LH-20 gel column chromatography, and was eluted with methanol to obtain epicatechin trans-coumarate; S9、制备表没食子儿茶素反式香豆酸酯;S9, preparing epigallocatechin trans-coumarate; 称取130.0mg步骤S5制得的4”-O-乙酰基-5,7,3’,4’,5’-O-五叔丁基二甲基硅基-表没食子儿茶素反式香豆酸酯于25mL圆底烧瓶中,加入476.0mg氟氢化钾,再加入8.0mL干燥的甲醇,50℃下反应6小时,反应产物浓缩后经LH-20凝胶柱层析,以甲醇洗脱后得到4”-O-乙酰基-表没食子儿茶素反式香豆酸酯;Weigh 130.0 mg of 4"-O-acetyl-5,7,3',4',5'-O-penta-tert-butyldimethylsilyl-epigallocatechin trans-aroma prepared in step S5 Add 476.0mg of potassium fluoride to a 25mL round-bottomed flask, then add 8.0mL of dry methanol, and react at 50°C for 6 hours. The reaction product is concentrated and eluted with methanol through LH-20 gel column chromatography Finally, 4"-O-acetyl-epigallocatechin trans-coumarate was obtained; 称取36.0mg的4”-O-乙酰基-表没食子儿茶素反式香豆酸酯于10mL圆底烧瓶中,加460.0mg醋酸铵,加入体积分数为80%甲醇水溶液2.0mL,室温反应5小时,反应产物经LH-20凝胶柱层析,以甲醇洗脱后得到表没食子儿茶素反式香豆酸酯;Weigh 36.0mg of 4”-O-acetyl-epigallocatechin trans-coumarate into a 10mL round bottom flask, add 460.0mg of ammonium acetate, add 2.0mL of 80% methanol aqueous solution, and react at room temperature After 5 hours, the reaction product was subjected to LH-20 gel column chromatography and eluted with methanol to obtain epigallocatechin trans-coumarate; 其中步骤S2、S3、S4、S5不分先后顺序,步骤S6、S7、S8、S9不分先后顺序。Wherein, steps S2, S3, S4, and S5 are in no particular order, and steps S6, S7, S8, and S9 are in no particular order.
2.根据权利要求1所述的一类羟基肉桂酰酯型儿茶素的制备方法,其特征在于,步骤S2中所述的3,4-O-二乙酰化咖啡酰氯通过以下方式制得:2. The preparation method of a class of hydroxycinnamoyl catechins according to claim 1, wherein the 3,4-O-diacetylated caffeoyl chloride described in step S2 is obtained in the following manner: 称取180.1mg咖啡酸于25mL圆底烧瓶中,加入0.3mL干燥的吡啶,0.5mL醋酸酐,在干燥管保护下室温搅拌过夜,加入水终止反应,经旋转蒸干后即可得到乙酰化咖啡酸即3,4-O-二乙酰化咖啡酸;将反应后的乙酰化咖啡酸转至50mL圆底烧瓶中,加入10mL亚硫酰氯,于90℃加热回流3小时即可得到3,4-O-二乙酰化咖啡酰氯,保存备用。Weigh 180.1 mg of caffeic acid into a 25 mL round bottom flask, add 0.3 mL of dry pyridine and 0.5 mL of acetic anhydride, stir overnight at room temperature under the protection of a drying tube, add water to terminate the reaction, and obtain acetylated coffee after rotary evaporation The acid is 3,4-O-diacetylated caffeic acid; transfer the reacted acetylated caffeic acid to a 50mL round bottom flask, add 10mL of thionyl chloride, and heat to reflux at 90°C for 3 hours to obtain 3,4- O-diacetylated caffeoyl chloride, kept for future use. 3.根据权利要求1所述的一类羟基肉桂酰酯型儿茶素的制备方法,其特征在于,步骤S3中所述的4-O-乙酰化香豆酰氯通过以下方式制得:3. the preparation method of a class of hydroxycinnamoyl catechins according to claim 1, is characterized in that, the 4-O-acetylated coumaryl chloride described in step S3 is obtained by the following method: 称取656.0mg香豆酸于25mL圆底烧瓶中,加入0.8mL干燥的吡啶,1.0mL醋酸酐,在干燥管保护下室温搅拌过夜,加入水终止反应,经旋转蒸干后即可得到乙酰化香豆酸;将反应后的乙酰化香豆酸转至25mL圆底烧瓶中,加入3.0mL亚硫酰氯,于90℃加热回流3小时即可得到4-O-乙酰化香豆酰氯,保存备用。Weigh 656.0mg of coumaric acid into a 25mL round bottom flask, add 0.8mL of dry pyridine and 1.0mL of acetic anhydride, stir overnight at room temperature under the protection of a drying tube, add water to terminate the reaction, and obtain acetylation after rotary evaporation to dryness Coumaric acid: transfer the reacted acetylated coumaric acid to a 25mL round bottom flask, add 3.0mL thionyl chloride, and heat to reflux at 90°C for 3 hours to obtain 4-O-acetylated coumaryl chloride, which is stored for future use .
CN202010056390.XA 2020-01-18 2020-01-18 Preparation method and application of hydroxycinnamoyl ester type catechin Active CN111233810B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010056390.XA CN111233810B (en) 2020-01-18 2020-01-18 Preparation method and application of hydroxycinnamoyl ester type catechin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010056390.XA CN111233810B (en) 2020-01-18 2020-01-18 Preparation method and application of hydroxycinnamoyl ester type catechin

Publications (2)

Publication Number Publication Date
CN111233810A CN111233810A (en) 2020-06-05
CN111233810B true CN111233810B (en) 2023-03-21

Family

ID=70877932

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010056390.XA Active CN111233810B (en) 2020-01-18 2020-01-18 Preparation method and application of hydroxycinnamoyl ester type catechin

Country Status (1)

Country Link
CN (1) CN111233810B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7379415B2 (en) * 2021-06-01 2023-11-14 花王株式会社 Method for producing catechin conjugate
CN113429372B (en) * 2021-06-21 2023-10-13 安徽农业大学 Novel 3C-like protease inhibitor and preparation method and application thereof

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988008256A1 (en) * 1987-04-28 1988-11-03 University Patents, Inc. Dihydroflavonol derivatives useful as sweeteners
JPH0517352A (en) * 1991-07-03 1993-01-26 Mitsui Norin Kk Sucrase activity-inhibiting agent
JP2007231009A (en) * 2006-02-02 2007-09-13 Nagasaki Prefecture Composition for inhibiting increase in blood glucose level and food and drink containing the same
CN101182319A (en) * 2007-12-05 2008-05-21 中国海洋大学 A method for extracting epigallocatechin gallate from tea polyphenols
JP2009007272A (en) * 2007-06-27 2009-01-15 Toyama Prefecture New method for producing 3-o-substituted catechin derivative
CN101492440A (en) * 2008-01-24 2009-07-29 上海新康制药厂 Separation purification process for main catechin component in tea polyphenol and glycosidase activity
CN105503807A (en) * 2016-01-25 2016-04-20 安徽农业大学 Catechin derivative named as epicatechin trans caffeic acid ester and preparation method and application thereof
CN105949162A (en) * 2016-05-09 2016-09-21 许爱娥 Application of coffee acid derivative in treatment of vitiligo
CN106243077A (en) * 2016-07-29 2016-12-21 安徽农业大学 A kind of catechin-derived thing and the purposes in preparing acetylcholine esterase inhibition activity medicine thereof
CN108926553A (en) * 2017-05-26 2018-12-04 中国海洋大学 A kind of flavone compound is preparing the application in topoisomerase I inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696484B2 (en) * 1997-10-31 2004-02-24 University Of Chicago Office Of Technology And Intellectual Property Method and compositions for regulation of 5-alpha reductase activity

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988008256A1 (en) * 1987-04-28 1988-11-03 University Patents, Inc. Dihydroflavonol derivatives useful as sweeteners
JPH0517352A (en) * 1991-07-03 1993-01-26 Mitsui Norin Kk Sucrase activity-inhibiting agent
JP2007231009A (en) * 2006-02-02 2007-09-13 Nagasaki Prefecture Composition for inhibiting increase in blood glucose level and food and drink containing the same
JP2009007272A (en) * 2007-06-27 2009-01-15 Toyama Prefecture New method for producing 3-o-substituted catechin derivative
CN101182319A (en) * 2007-12-05 2008-05-21 中国海洋大学 A method for extracting epigallocatechin gallate from tea polyphenols
CN101492440A (en) * 2008-01-24 2009-07-29 上海新康制药厂 Separation purification process for main catechin component in tea polyphenol and glycosidase activity
CN105503807A (en) * 2016-01-25 2016-04-20 安徽农业大学 Catechin derivative named as epicatechin trans caffeic acid ester and preparation method and application thereof
CN105949162A (en) * 2016-05-09 2016-09-21 许爱娥 Application of coffee acid derivative in treatment of vitiligo
CN106243077A (en) * 2016-07-29 2016-12-21 安徽农业大学 A kind of catechin-derived thing and the purposes in preparing acetylcholine esterase inhibition activity medicine thereof
CN108926553A (en) * 2017-05-26 2018-12-04 中国海洋大学 A kind of flavone compound is preparing the application in topoisomerase I inhibitor

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"Identification and quantification of hydroxycinnamoylated catechins in tea by targeted UPLC-MS using synthesized standards and their potential use in discrimination of tea varieties";Wei Wang et al.;《LWT -FoodScienceandTechnology》;第142卷;第110963号 *
"Microencapsulation and the Characterization of Polyherbal Formulation (PHF) Rich in Natural Polyphenolic Compounds";Syed Ammar Hussain et al.;《nutrients》;第10卷;第843号 *
"Synthesis and structureeactivity relationship of 3-O-acylated "(-)-epigallocatechins as 5α-reductase inhibitors;Shu Fu Lin et al.;《European Journal of Medicinal Chemistry》;第45卷;第6068-6076页 *
"Towards the discovery of drug-like epigallocatechin gallate analogs as Hsp90 inhibitors";Rohit Bhat et al.;《Bioorganic & Medicinal Chemistry Letters》;第24卷;第2263-2266页 *

Also Published As

Publication number Publication date
CN111233810A (en) 2020-06-05

Similar Documents

Publication Publication Date Title
Gao et al. α-Glucosidase inhibition of 6-hydroxyflavones. Part 3: Synthesis and evaluation of 2, 3, 4-trihydroxybenzoyl-containing flavonoid analogs and 6-aminoflavones as α-glucosidase inhibitors
Yuan et al. New maplexins F–I and phenolic glycosides from red maple (Acer rubrum) bark
CN101003528B (en) En-kaurene diterpenoids and derivatives thereof, preparation methods and uses thereof
CN111233810B (en) Preparation method and application of hydroxycinnamoyl ester type catechin
CN102079700A (en) Method for synthesizing novel tetracyclic diterpene compound from stevioside
CN101182319A (en) A method for extracting epigallocatechin gallate from tea polyphenols
SU1072805A3 (en) Process for preparing derivatives of flavan or their salts
ITMI20002201A1 (en) DRUGS FOR DIABETES
Takanashi et al. New benzofurans related to egonol from immature seeds of Styrax obassia
Zhou et al. Synthesis and antitumor activity of scopoletin derivatives
CN101966172B (en) New purpose of caffeic acid and derivatives thereof
Shao et al. Synthesis, characterization, and antiradical activity of 6-hydroxygenistein
Joshi et al. Quinones and other constituents from the roots of Tecomella undulata
CN101724008A (en) Marsdenia tenacissima C21 steroidal glycoside converted product and preparation method and application thereof
Kuramochi et al. Synthesis and structure–activity relationships of dehydroaltenusin derivatives as selective DNA polymerase α inhibitors
Yu et al. Structural optimization of caffeoyl salicylate scaffold as no production inhibitors
CN101792478A (en) Light affinity labelling small molecular probe based on maslinic acid and preparation method thereof
CN101966194A (en) New application of scutellarin and derivatives thereof
Thomas et al. Isolation, structure, and synthesis of hymenoxin, a new flavone from Hymenoxys scaposa
JPH02138291A (en) Measuring method and measuring reagent for novel oligoglucoside derivative alpha- amylase
CN102863419A (en) Flavan3-alcohol acetylate and preparation method and application thereof
CN104672191B (en) Cardiac phenol E1 compound and its preparation method and application
CN108125962B (en) Application of benzo [ d ] aza-quinazoline compound in preparation of drugs for treating lung cancer
Toshifumi et al. Synthesis of N-acetylglucosaminides of unconjugated and conjugated bile acids
CN101891730A (en) Synthesis and Pharmaceutical Application of 7-Alkoxymethyl Hesperetin

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant